The Mind-Boggling Hypocrisy of the DEA

September 15, 2008

Since the late 1980s, the DEA, in cooperation with the FDA, has successfully marketed and sold the public their own version of “medical marijuana” - it’s less effective, less safe and more costly - yet it’s categorized as a Schedule 3 drug on the Controlled Substances Act, while cannabis remains a Schedule 1 drug.

To date, 36 U.S. states have passed legislation recognizing the therapeutic value of cannabis, while 12 states have legalized the plant for medicinal use upon obtaining a physican’s recommendation. Over 17,000 studies have been done on cannabinoids (the main compounds found in cannabis). And dozens of leading state, national, and international organizations have endorsed the use of cannabis for medicinal purposes — including the American Public Health Association and the American Preventive Medical Association. Cannabis has been shown in clinical studies to alleviate pain and counteract the effects of dozens of illnesses, including AIDS, Alzheimer’s, Arthritis, HIV, Gastrointestinal Disorders, and Multiple Sclerosis. The recommendations from medical doctors and researchers in support of the medicinal qualities of cannabis is overwhelming, and study-after-study have proven its effectiveness. So why does the federal government still classify cannabis as a schedule 1 drug - claiming there’s no accepted medical use?

Where the Presidential Candidates Stand on Medical Marijuana

September 15, 2008

There are some stark differences between the answers and attitudes towards cannabis by the presidential candidates. We’ve dug up some evidence for each candidate to show where they stand on this controversial issue.

Irv Rosenfeld’s Medical Marijuana Testimony

September 12, 2008

Irv Rosenfeld has been receiving 300 joints per month (10 ounces to be exact) since 1983 from the federal government. This is the same government that insists there is no medicinal value for cannabis and proclaims it’s a schedule one drug.